Knowledge Is Safety: The Time Is Ripe for Hepatitis E Virus Blood Donor Screening.
作者信息
Vollmer Tanja, Knabbe Cornelius, Dreier Jens
机构信息
Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
出版信息
Transfus Med Hemother. 2016 Nov;43(6):425-427. doi: 10.1159/000450794. Epub 2016 Nov 2.
Abstract
摘要
相似文献
1
Knowledge Is Safety: The Time Is Ripe for Hepatitis E Virus Blood Donor Screening.
Transfus Med Hemother. 2016 Nov;43(6):425-427. doi: 10.1159/000450794. Epub 2016 Nov 2.
2
The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.
Transfusion. 2015 Jun;55(6):1206-13. doi: 10.1111/trf.12962. Epub 2014 Dec 15.
3
New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays.
Transfusion. 1998 Jan;38(1):56-9. doi: 10.1046/j.1537-2995.1998.38198141499.x.
4
Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety.
Asian J Transfus Sci. 2015 Jul-Dec;9(2):199-202. doi: 10.4103/0973-6247.154250.
5
[The screening of donor blood on antibodies to nuclear antigen of hepatitis B virus as a tool of increasing of safety of transfusion for patients with diseases of blood system.].
Klin Lab Diagn. 2016;61(5):311-316. doi: 10.18821/0869-2084-2016-61-5-311-316.
6
The History and Challenges of Blood Donor Screening in China.
Transfus Med Rev. 2017 Apr;31(2):89-93. doi: 10.1016/j.tmrv.2016.11.001. Epub 2016 Nov 12.
7
Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose.
Front Med (Lausanne). 2018 Feb 1;5:5. doi: 10.3389/fmed.2018.00005. eCollection 2018.
8
Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
Lancet. 1999 Jan 30;353(9150):359-63. doi: 10.1016/S0140-6736(98)06318-1.
9
Detection of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in postmortem blood specimens using infectious disease assays licensed for cadaveric donor screening.
Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12825. Epub 2018 Jan 19.
10
Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results.
Transfusion. 1998 Oct;38(10):905-7. doi: 10.1046/j.1537-2995.1998.381098440853.x.
引用本文的文献
1
Blood Donor Screening for Hepatitis E Virus in the European Union.
Transfus Med Hemother. 2019 Apr;46(2):95-103. doi: 10.1159/000499121. Epub 2019 Mar 14.
2
Transmission and Epidemiology of Hepatitis E Virus Genotype 3 and 4 Infections.
Cold Spring Harb Perspect Med. 2018 Nov 1;8(11):a032144. doi: 10.1101/cshperspect.a032144.
3
Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose.
Front Med (Lausanne). 2018 Feb 1;5:5. doi: 10.3389/fmed.2018.00005. eCollection 2018.
本文引用的文献
1
Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011.
Euro Surveill. 2016 Sep 1;21(35). doi: 10.2807/1560-7917.ES.2016.21.35.30332.
2
Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.
Lancet. 2014 Nov 15;384(9956):1766-73. doi: 10.1016/S0140-6736(14)61034-5. Epub 2014 Jul 28.
3
Hepatitis E screening for blood donations: an urgent need?
Lancet. 2014 Nov 15;384(9956):1729-30. doi: 10.1016/S0140-6736(14)61187-9. Epub 2014 Jul 28.
4
Past and present of hepatitis E in the Netherlands.
Transfusion. 2014 Dec;54(12):3092-6. doi: 10.1111/trf.12733. Epub 2014 May 29.
5
Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma.
Vox Sang. 2014 Oct;107(3):213-9. doi: 10.1111/vox.12156. Epub 2014 May 15.
6
Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors.
J Clin Microbiol. 2014 Jun;52(6):2150-6. doi: 10.1128/JCM.03578-13. Epub 2014 Apr 16.
7
Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.
Transfus Med Hemother. 2014 Feb;41(1):45-51. doi: 10.1159/000357103. Epub 2013 Dec 19.
8
Hepatitis E transmission by transfusion of Intercept blood system-treated plasma.
Blood. 2014 Jan 30;123(5):796-7. doi: 10.1182/blood-2013-09-524348.
9
Should we screen blood products for hepatitis E virus RNA ?
Lancet. 2014 Jan 18;383(9913):218. doi: 10.1016/S0140-6736(14)60072-6.
10
Hepatitis E virus infection.
Clin Microbiol Rev. 2014 Jan;27(1):116-38. doi: 10.1128/CMR.00057-13.
Zotero 插件